IEG Vu is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


EU outlines progress on ED criteria

The European Commission’s Health Directorate General is planning to screen “almost all” active ingredients covered by EU agrochemical and biocide regulations as part of its programme to develop criteria to identify endocrine disruptors (EDs). The screening will aim to define which ais fall under the different identification options that the Commission put forward in a roadmap in 2014. The roadmap suggested various combinations of using the UN WHO’s ED definition together with categories based on strength of evidence or potency. An update on the ED programme was presented by EU Health Commissioner Vytenis Andriukaitis to members of the European Parliament in May. It completed a series of three meetings held over the last month for stakeholders, EU Ministers and MEPs.



What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts